Updated on 2023/09/28

写真a

 
SHIRATORI Yoshimune
 
Organization
Nagoya University Hospital Medical IT Center Professor of Hospital
Title
Professor of Hospital

Degree 1

  1. 博士(医学) ( 1992.3   岐阜大学 ) 

Research History 10

  1. 岐阜大学医学部附属病院医療情報部 准教授

    2007.4 - 2013.12

      More details

    Country:Japan

  2. 岐阜大学医学部附属病院医療情報部 助教授

    2005.2 - 2007.3

      More details

    Country:Japan

  3. 岐阜大学医学部附属病院医療情報部 助手

    2002.7 - 2005.1

      More details

    Country:Japan

  4. 文部科学省科学研究費補助金による海外派遣4カ月 IGBMC Strasbourg,France

    2000.10 - 2002.6

      More details

    Country:Japan

  5. 岐阜大学医学部内科学第1講座 助手

    1999.6 - 2000.9

      More details

    Country:Japan

▼display all

Education 2

  1. Gifu University   Graduate School, Division of Medical Science

    - 1992.3

      More details

    Country: Japan

  2. Gifu University   Faculty of Medicine

    - 1986.3

      More details

    Country: Japan

 

Papers 124

  1. Effects of glutamic acid analogues on identifiable giant neurones, sensitive to β-hydroxy-L-glutamic acid, of an African giant snail (Achatina fulica Férussac).

    Nakajima T, Nomoto K, Ohfune Y, Shiratori Y, Takemoto T, Takeuchi H, Watanabe K.

    British J Pharmacol   Vol. 86   page: 645-654   1985

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  2. Production of Leukotriene B4 in Parenchymal and Sinusoidal Cells of The liver in Rats Treated Simultaneously with D-galactosamine and Endotoxin

    Shiratori Y, Moriwaki H, Muto Y, Ohnishi H, Kato M, Asano F.

    J Gastroenterol (Gastroenterologia Japonica)   Vol. 24   page: 640-645   1989

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  3. A significant correlation of leukotriene B4 production rate between peripheral blood mononuclear cells and hepatic adherent cell fraction in rats with acute hepatic failure.

    Shiratori Y, Asano F, Ohnishi H, Moriwaki H, Muto Y.

    J Gastroenterol (Gastroenterologia Japonica)   Vol. 25   page: 786   1990

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  4. Elevated interleukin-6 levels in sera of patients with fulminant hcpatitis.

    Shiratori Y, Moriwaki H, Kawashima Y, Ando K, Asano F, Shimazaki M, Ohnishi H, Muto Y, Okuno M.

    J Gastroenterol (Gastroenterologia Japonica)   Vol. 26   page: 232   1991

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  5. ヒト腫瘍由来培養株細胞における合成レチノイドの増殖抑制効果

    福富尉,白鳥義宗,山内治,福富尚子,足立定司,二ノ宮三生,森脇久隆,武藤泰敏,大森正英

    岐阜大医紀   Vol. 39   page: 195-196   1991

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

▼display all

Books 50

  1. 肝類洞壁細胞研究の進歩 第2巻(肝ビタミンA代謝におけるstellate cell とparenchymal cellの機能相関)

    森脇久隆.葛西哲宏.白鳥義宗.武藤泰敏( Role: Sole author)

    国際医書出版(東京)  1989 

     More details

    Language:Japanese

  2. 肝類洞壁細胞研究の進歩 第2巻(D-galactosamine + lipopolysaccharide 急性肝不全モデルにおける肝実質細胞ならびに肝類洞壁細胞のロイコトリエン産生に関する研究)

    白鳥義宗,森脇久隆,浅野文祐,大西弘生,武藤泰敏,奥野正隆.( Role: Joint author)

    国際医書出版(東京)  1989 

     More details

    Language:Japanese

  3. 臨床生理学シリーズ5 肝臓(ビタミンA. D. K の貯蔵と輸送)

    森脇久隆,白鳥義宗,武藤泰敏.( Role: Joint author)

    南江堂(東京)  1990 

     More details

    Language:Japanese

  4. 消化器疾患の防御機構(肝疾患とプロスタノイドーとくに劇症肝炎とのかかわりについて)

    森脇久隆,大西弘生,永木正仁,白鳥義宗,浅野文祐,武藤泰敏.( Role: Joint author)

    現代医療社(東京)  1990 

     More details

    Language:Japanese

  5. 肝類調壁細胞研究の進歩第3巻(肝壊死に及ぼすサイトカインの役割に関する実験的検討- TNF を中心として一)

    劉柿,大西弘生,安藤量基,白鳥義宗,前田晃男,永木正仁,杉山宏,名倉一夫,森脇久隆,武藤泰敏.( Role: Joint author)

    国際医書出版(東京)  1991 

     More details

    Language:Japanese

▼display all

Presentations 1

  1. 電子カルテ時代のPOS

    白鳥 義宗

    第27回日本POS 衣料学会大会 (札幌) 

     More details

    Event date: 2005.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

KAKENHI (Grants-in-Aid for Scientific Research) 4

  1. Efforts for standardization of electronic medical care process using OAT unit

    Grant number:23K09527  2023.4 - 2026.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator 

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

  2. A study on the public nature of healthcare system supported by public funding and its role as a public good

    Grant number:20H03912  2020.4 - 2023.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Authorship:Coinvestigator(s) 

  3. Orality and Narrative Technique in Pain Clinic

    Grant number:19KT0027  2019.7 - 2022.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OYAMA Shintaro

      More details

    Authorship:Coinvestigator(s) 

    The goal of this study was to develop a medical care learning tool to systematize orality techniques for physicians in the treatment of chronic pain patients. The latter was possible to implement using existing libraries, but the accuracy of facial expressions could not be improved due to the principle of wearing a mask in the examination room. Based on the existing machine learning model, we conducted a dialogue (clinical) test, conducted reinforcement learning with the data, and constructed a model that adapted the Softmax function to the five classes of emotional parameter outputs. The results were reported at a conference.

  4. Research of liaison the critical path and standard of cancer

    Grant number:17K09233  2017.4 - 2020.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    SHIRATORI YOSHIMUNE

      More details

    Authorship:Principal investigator 

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    Our aim is that effective use of regional collaboration clinical pathway for hepatocellular carcinoma with high recurrence rate and clearly defined high-risk group improves intermediate and final outcomes study. If we can derive the same outcome as a specialist even if we are not a specialist by using the regional collaboration clinical pathway, we believe that we can contribute to the quality of regional medical care. It was revealed that it is equivalent to a specialist even if it is not a specialist. We have improved the quality of medical care by using the clinical pathway method, as a goal of the optimal preventive and therapeutic measures against difficult-to-treat diseases such as cancer.

 

Teaching Experience (On-campus) 1

  1. 医療情報学

    2014